Pharma Bro Martin Shkreli ordered to return $64M for jacking up drug price
CNBC's Shep Smith reports that 'Pharma Bro' Martin Shkreli was ordered to return $64 million for jacking up the price of a life-saving drug. He was also banned from ever working in the pharmaceutical industry again.
UP NEXT
NOW PLAYING: Markets
Pharma Bro Martin Shkreli ordered to return $64M for jacking up drug price
CNBC
UP NEXT
-
Right now SPACs have a credibility problem, says Manhattan Venture Partner's Rao
CNBC
-
'Right now, it's still very much a traders market,' says LPL Financial's Quincy Krosby
-
It's going to be harder for some price increases to get through in consumer staples, says RBC's Modi
-
Bitcoin crosses $30,000, Ethereum preps upgrade and FTX U.S. launches stock trading: CNBC Crypto World
-
Tight housing supply fuels higher prices as existing median home price rises nearly 15% annually
-
Grocery chain Albertsons to start using self-checkout carts
-
It looks like the volatility is here to stay, says Ally Invest's Lindsey Bell
-
Buy names in tech that have been beaten down, says Destination Wealth's Michael Yoshikami
-
Once inflation expectations settle, we'll see the yield curve flatten, says Wells Fargo's Paul Christopher
-
Retailers focused on low-income consumers will face tough sledding, says Truist's Scot Ciccarelli
-
Final Trades: TJX, JPMorgan, NXP Semi & more
-
Things in U.S. may get as challenging as Europe, says First Eagle's Matthew McLennan
-
'I'm still a bull on Bitcoin because it's a great hedge against inflation,' says Tim Draper
-
'I think Docusign would be really valuable for Salesforce,' says RBC's Jaluria
-
Hedge fund Melvin Capital returns cash to investors
-
Apple reportedly shows new headset to board
